NCT07013708

Brief Summary

Tendinopathy is an inflammatory process that occurs in and around the tendon when both are affected by a certain injury. In the case of the supraspinatus muscle it is one of the most frequent causes of shoulder pain. To test the efficacy of laser treatment in reducing shoulder pain caused by supraspinatus muscle tendinopathy. A randomized controlled clinical trial was carried out in which a physiotherapy intervention was performed using therapeutic laser for four weeks, to observe the influence on the pain generated by supraspinatus muscle tendinopathy in the shoulder. A sample of 82 patients was recruited and randomly divided into two groups: experimental group and control group. Laser therapy was applied to the first group and to the second group it was applied as a placebo

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2025

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

June 2, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

June 10, 2025

Completed
Last Updated

June 13, 2025

Status Verified

June 1, 2025

Enrollment Period

6 months

First QC Date

June 2, 2025

Last Update Submit

June 10, 2025

Conditions

Keywords

shoulderlaserplaceboTendinopathy

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale

    pain scale where 0 is the lowest possible pain score and 10 is the maximum possible pain score

    12 weeks

Secondary Outcomes (2)

  • Range of movement

    12 weeks

  • pain threshold

    12 weeks

Study Arms (2)

Laser treatment

EXPERIMENTAL

Patients diagnosed with laser-treated supraspinatus tendinopathy

Device: Laser

Placebo Group

ACTIVE COMPARATOR

Patients diagnosed with supraspinatus tendinopathy treated with placebo

Other: Placebo

Interventions

LaserDEVICE

High frequency laser device

Laser treatment
PlaceboOTHER

Same device but without pressing the ON button

Placebo Group

Eligibility Criteria

Age30 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 30-65 years.
  • Present a 3 or higher on the visual analogue scale in the shoulder.
  • Adequate cognitive capacity for comprehension.
  • Tendinopathy of the rotator cuff confirmed by ultrasound at the study center, either by inflammation of the tendon, presence of hypoechoic zones, calcification, fibrillar disorganization and/or neovascularization in the supraspinatus muscle.
  • Pain in the proximal side of the arm that is aggravated by abduction.

You may not qualify if:

  • Laser-specific contraindications (e.g., tumors, presence of pacemaker or defibrillator, pregnancy, etc.).
  • History of glenohumeral fracture and rheumatoid arthritis.
  • Rheumatic, neurological or structural polymyalgia affecting the joint.
  • Previous surgeries.
  • Pregnant or breastfeeding women.
  • Taking anticoagulants or antiaggregants.
  • Diabetes mellitus.
  • Cardiac dysfunctions.
  • Infiltrative and/or rehabilitative treatment in the two months prior to recruitment.
  • Pre-existing diseases associated with pain in the upper extremities.
  • Difficulties of follow-up.
  • Depression.
  • Treatment with another intervention, during the development of the study will not be able to perform.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Pontificia de Salamanca

Salamanca, Spain

Location

Related Publications (8)

  • So BCL, Lau SCT, Kwok WY, Tse DHT, Man SS. Investigating The Association Between Supraspinatus Tendon Abnormality, Shoulder Pain and Isokinetic Strength in Elite Swimmers: A Cross-Sectional Study. J Sports Sci Med. 2023 Mar 1;22(1):17-27. doi: 10.52082/jssm.2023.17. eCollection 2023 Mar.

  • Rodeo SA, Nguyen JT, Cavanaugh JT, Patel Y, Adler RS. Clinical and Ultrasonographic Evaluations of the Shoulders of Elite Swimmers. Am J Sports Med. 2016 Dec;44(12):3214-3221. doi: 10.1177/0363546516657823. Epub 2016 Aug 9.

  • Blevins FT. Rotator cuff pathology in athletes. Sports Med. 1997 Sep;24(3):205-20. doi: 10.2165/00007256-199724030-00009.

  • Lewis JS. Rotator cuff tendinopathy: a model for the continuum of pathology and related management. Br J Sports Med. 2010 Oct;44(13):918-23. doi: 10.1136/bjsm.2008.054817. Epub 2009 Apr 12.

  • Haslerud S, Magnussen LH, Joensen J, Lopes-Martins RA, Bjordal JM. The efficacy of low-level laser therapy for shoulder tendinopathy: a systematic review and meta-analysis of randomized controlled trials. Physiother Res Int. 2015 Jun;20(2):108-25. doi: 10.1002/pri.1606. Epub 2014 Dec 2.

  • Tumilty S, Munn J, McDonough S, Hurley DA, Basford JR, Baxter GD. Low level laser treatment of tendinopathy: a systematic review with meta-analysis. Photomed Laser Surg. 2010 Feb;28(1):3-16. doi: 10.1089/pho.2008.2470.

  • Notarnicola A, Covelli I, Macchiarola D, Bianchi FP, Cassano GD, Moretti B. The Efficacy of Temperature-Controlled High-Energy Polymodal Laser Therapy in Tendinopathy of the Shoulder. J Clin Med. 2023 Mar 29;12(7):2583. doi: 10.3390/jcm12072583.

  • Elsodany AM, Alayat MSM, Ali MME, Khaprani HM. Long-Term Effect of Pulsed Nd:YAG Laser in the Treatment of Patients with Rotator Cuff Tendinopathy: A Randomized Controlled Trial. Photomed Laser Surg. 2018 Sep;36(9):506-513. doi: 10.1089/pho.2018.4476.

MeSH Terms

Conditions

TendinopathyPain

Interventions

Lasers

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesTendon InjuriesWounds and InjuriesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Optical DevicesEquipment and SuppliesRadiation Equipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Masking Details
simple
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 2, 2025

First Posted

June 10, 2025

Study Start

June 1, 2024

Primary Completion

November 30, 2024

Study Completion

May 24, 2025

Last Updated

June 13, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations